BSGM:NSD-BioSig Technologies, Inc (USD)

COMMON STOCK | Medical Devices | NSD

Last Closing Price

USD 4.64

Change

0.00 (0.00)%

Market Cap

USD 0.14B

Volume

0.25M

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

BioSig Technologies, Inc., a medical device company, engages in developing and commercializing a proprietary biomedical signal processing technology platform to extract information from physiologic signals. The company's proprietary product include precise uninterrupted real-time evaluation of electrograms electrophysiology system, a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology procedures in an electrophysiology laboratory under the supervision of licensed healthcare practitioners who are responsible for interpreting the data. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation and ventricular tachycardia. BioSig Technologies, Inc. was founded in 2009 and is headquartered in Westport, Connecticut.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-11-28 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ALGN Align Technology, Inc

N/A

USD37.49B 21.64 88.58
PODD Insulet Corporation

N/A

USD16.58B 571.55 148.92
LVGO Livongo Health, Inc

N/A

USD14.20B N/A N/A
ABMD Abiomed, Inc

N/A

USD12.29B 59.76 46.25
BRKR Bruker Corporation

N/A

USD7.76B 50.06 24.76
TNDM Tandem Diabetes Care, Inc

N/A

USD5.64B N/A N/A
IART Integra LifeSciences Holdings ..

N/A

USD4.69B 84.27 21.88
SDC SmileDirectClub, Inc

N/A

USD4.67B N/A N/A
WMGI Wright Medical Group N.V

N/A

USD3.90B N/A 50.67
SWAV ShockWave Medical, Inc

N/A

USD3.40B N/A N/A

ETFs Containing BSGM

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Devices)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -21.62% 35% F 23% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -21.62% 35% F 21% F
Trailing 12 Months  
Capital Gain -31.66% 27% F 13% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -31.66% 27% F 12% F
Trailing 5 Years  
Capital Gain 256.92% 90% A- 89% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 256.92% 90% A- 89% B+
Average Annual (5 Year Horizon)  
Capital Gain 73.05% N/A N/A 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 73.05% N/A N/A 95% A
Risk Return Profile  
Volatility (Standard Deviation) 110.42% N/A N/A 8% F
Risk Adjusted Return 66.16% N/A N/A 81% B-
Market Capitalization 0.14B 41% F 32% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Devices)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 4.09 57% F 34% F
Price / Cash Flow Ratio -9.07 60% D- 78% C+
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -297.60% 4% F 2% F
Return on Invested Capital -456.49% 10% F 1% F
Return on Assets -161.38% 2% F 0% N/A
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio 5.33 43% F 30% F
Short Percent 10.38% 23% F 21% F
Beta 1.64 26% F 23% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector